Gide advises BioMérieux on Hybiome acquisition
Gide has advised BioMérieux, a specialist in the field of in-vitro diagnostics, on its acquisition of a majority stake in Suzhou Hybiome Biomedical Engineering Co, Ltd. As part of the deal, the French listed company (Euronext Paris: BIM) acquired 54 per cent of the shares in Hybiome for a valuation